The RetInSight GA Monitor for Geographic Atrophy (GA)
Welcome to the future of geographic atrophy management with the RetInSight GA Monitor. Our groundbreaking AI-based technology brings forth a new era in GA segmentation and visualization, making the invisible visible.
Key features of the RetInSight GA Monitor
- AI-based segmentation: Advanced AI algorithms enable precise segmentation of GA areas
- Complete disease activity assessment: Measure and visualize disease activity and therapeutic efficacy across all aspects, including photoreceptor (PR) degeneration12, retinal pigment epithelium (RPE) loss consistent with FAF13, and PR/RPE overlap14
- Enhanced disease monitoring: Visualize and track disease progression, allowing for precise and timely interventions
The RetInSight GA Monitor fulfills all MDR 2017/745 requirements for class IIa medical devices as Clinical Decision Support Systems (CDSS) for the monitoring of patients with GA.
How the RetInSight GA Monitor will benefit your clinical routine
The GA Monitor is specifically designed to empower GA treatment, enabling visualization and quantification of photoreceptor (PR) and retinal pigment epithelium (RPE) loss.
- Unique photoreceptor measurement: Be at the forefront of GA treatment with our unique ability to measure photoreceptor integrity loss, the very essence of vision. With the help of a specifically trained AI-supported algorithm the level and extent of photoreceptor thinning, referred to as EZ (ellipsoid zone) attenuation, is identified by a cloud-based software.
- Differentiation of progressors: Identify slow vs. fast progressors at the first presentation, enabling personalized treatment plans and improved patient outcomes.
- Efficient workflow: Integrate GA management seamlessly into your current optical coherence tomography (OCT) routine, streamlining workflow and enhancing efficiency with just one mouse click.
Empowering GA treatment through visualization and quantification of PR and RPE loss
As a trusted leader in retinal care, RetInSight invites you to explore the GA Monitor and experience the next generation of GA management. Our innovative technology will empower you to make informed treatment decisions based on precise measurements and visualizations of PR and RPE loss, all while remaining committed to preserving your patients’ vision throughout their lifetime.
For more information and details on the GA Monitor, please get in touch with our team. Together, let’s revolutionize the way we manage and treat geographic atrophy.